ATAD2 BRD mediates liquid-liquid phase separation of ATAD2 to promote histone acetylation

This study reveals that the ATAD2 bromodomain mediates liquid-liquid phase separation to promote histone H4 acetylation, thereby facilitating chromatin remodeling and upregulating key genes such as C-MYC, CCND3, and ATF2.

The Gist

The Big Picture: The "Molecular Party Planner"

Imagine your cell's DNA is a massive, dusty library. Inside this library, there are millions of books (genes) that tell the cell how to behave. Sometimes, the cell needs to read specific books very quickly to grow or divide. To do this, it needs to open the books and make them easy to read. This process is called chromatin remodeling.

Enter ATAD2, a protein that acts like a super-efficient party planner for this library. Its job is to gather the right tools and people to open the books and get the work done.

For a long time, scientists knew ATAD2 had a special tool called a Bromodomain (BRD) that could grab onto "acetylated" tags (like sticky notes) on the DNA books. But they didn't understand how it gathered everyone together so efficiently.

This new study reveals that ATAD2 doesn't just walk around the library looking for work; it actually creates a liquid drop to do the job.

---

1. The Magic of "Liquid Drops" (Phase Separation)

The Concept: Liquid-Liquid Phase Separation (LLPS).
The Analogy: Think of oil and vinegar. If you shake them, they mix, but if you let them sit, the oil separates and forms little floating droplets.

The researchers discovered that the ATAD2 protein does something similar. When there are enough of them, they don't just float around individually. They clump together to form tiny, spherical liquid droplets inside the cell nucleus.

• Why is this cool? Imagine trying to build a house. If you have your bricks, cement, and workers scattered all over the city, it takes forever. But if you put them all inside a single, moving construction truck (the droplet), the work happens super fast.
• The Proof: The scientists shined a laser on these droplets to "bleach" the color out of a spot. The color came back instantly. This proved the droplets weren't solid rocks; they were liquid, meaning the proteins inside were flowing and mixing freely.

2. The "Handle" That Starts the Party

The Concept: The Bromodomain (BRD) is the driver.
The Analogy: Imagine the ATAD2 protein is a long, complex machine with two main parts: a heavy engine (the AAA+ ATPase) and a special handle (the BRD).

The team tested what happened if they removed the handle:

• Full Machine: Forms perfect liquid droplets.
• Machine without the Handle: The droplets barely form or fall apart.
• Machine with a broken handle: No droplets at all.

The Takeaway: The Bromodomain (BRD) is the specific part of the protein that acts as the "glue" or the "magnet" that pulls everything together into that liquid drop. Without this specific part, the party never starts.

3. Changing Shape to Get the Job Done

The Concept: Conformational Transition.
The Analogy: Think of a caterpillar turning into a butterfly.

The study found that as these droplets form, the ATAD2 proteins actually change their shape. They shift from a structure made of spirals (alpha-helices) to a structure made of flat sheets (beta-sheets). It's like the proteins are folding themselves into a new, more efficient configuration specifically to work inside the droplet.

Interestingly, this shape-shifting depends on "chemical zippers" (disulfide bonds). If you cut these zippers, the proteins can't change shape, and the droplets don't form properly.

4. Why Does This Matter? (The Result)

The Concept: Histone Acetylation and Gene Activation.
The Analogy: The "Sticky Note" System.

Inside the droplet, ATAD2 acts as a high-speed assembly line.

1. Concentration: Because everyone is packed into the tiny liquid drop, the enzymes that add "acetyl" tags (sticky notes) to the DNA are right next to the DNA.
2. Efficiency: This makes the process of tagging the DNA much faster and more efficient than if the proteins were floating around separately.
3. The Outcome: These tags tell the cell to turn on specific "growth" genes. The study found that when ATAD2 forms these droplets, it turns up the volume on genes like C-MYC and CCND3.
   • C-MYC and CCND3 are like the "Go" buttons for the cell cycle. They tell the cell, "It's time to divide and grow!"

5. The "Safety Valve"

The study also noticed something interesting about a gene called ATF2. When ATAD2 gets too excited and turns on too many growth genes, ATF2 also turns up.

• The Analogy: It's like a thermostat. If the room gets too hot (too much acetylation/growth), the thermostat (ATF2) kicks in to cool things down and prevent the system from overheating. This suggests the cell has a built-in safety mechanism to keep the "party" from getting out of control.

Summary: What Did We Learn?

This paper tells us that ATAD2 is a master organizer. It uses its special Bromodomain to gather itself and other proteins into tiny liquid droplets. Inside these droplets, the proteins change shape and work together like a high-speed factory to tag DNA, which tells the cell to grow and divide.

Why should you care?
ATAD2 is often overactive in cancers (like breast, liver, and lung cancer). If cancer cells are using these "liquid droplets" to grow uncontrollably, scientists might be able to design drugs that stop the droplets from forming. If you break the droplet, you break the assembly line, and you might be able to stop the cancer from growing.

In a nutshell: ATAD2 builds a liquid construction zone to speed up cell growth. If we can stop the construction zone from being built, we might be able to stop the cancer.

Technical Summary

1. Problem Statement

ATAD2 is a nuclear chromatin regulator and oncogenic transcriptional co-activator highly expressed in various malignancies. While its C-terminal Bromodomain (BRD) is known to recognize acetylated lysine residues (specifically H4K5ac) and its AAA+ ATPase domains form a hexameric complex, the native intracellular structural configuration of full-length ATAD2 remains poorly defined. Specifically, the mechanisms by which the ATAD2 BRD recruits acetylated histones and regulates histone acetylation patterns in vivo are unclear. Existing literature suggests bromodomain-containing proteins may form Liquid-Liquid Phase Separation (LLPS) condensates, but it was unknown if ATAD2 undergoes LLPS and how this physical state influences its biological function in chromatin remodeling.

2. Methodology

The study employed a multidisciplinary approach combining structural biology, biophysics, cell biology, and biochemistry:

• Protein Purification & Mutagenesis: Recombinant full-length ATAD2 (residues 1–1390) and various C-terminal truncation mutants (DeC, DeBRD, DeLinker-BRD) were expressed and purified.
• In Vitro Phase Separation Assays:
  • Transmission Electron Microscopy (TEM): To visualize the morphology of ATAD2 assemblies.
  • Confocal Microscopy & Fluorescence Recovery After Photobleaching (FRAP): Proteins were labeled with fluorescent tags (TAMRA or EGFP) to observe droplet formation and measure internal fluidity (liquid-like properties).
  • Chemical Inhibition: Treatment with GSK8814 (a potent ATAD2 BRD inhibitor) to assess the dependency of LLPS on BRD function.
• Structural Analysis:
  • Circular Dichroism (CD) Spectroscopy: To monitor secondary structural changes (α-helix vs. β-sheet) at varying protein concentrations.
  • Thioflavin T (ThT) Fluorescence: To quantify β-sheet content over time.
  • Liquid-State NMR (1H-15N HSQC): To observe conformational dynamics and the impact of redox conditions (DTT treatment) on disulfide bond formation.
• Biochemical Assays:
  • Acetylation Kinetics: An in vitro assay using H4K5 peptides and the acetyltransferase EP300 to measure Coenzyme A (CoA) production in the presence of ATAD2 BRD.
  • Photo-crosslinking: Use of SDA (Sulfo-NHS-diazirine) to lock ATAD2 BRD in a non-phase-separating state to test causality.
• Cellular Studies:
  • Live-cell Imaging: Transfection of HeLa cells with EGFP-tagged constructs to monitor nuclear puncta formation.
  • Biochemical Fractionation: Sucrose gradient centrifugation to isolate ATAD2 droplets from cell lysates for immunoblotting.
  • Gene Expression Analysis: qPCR/Western blotting to assess levels of H4K5ac and transcription of downstream targets (C-MYC, CCND3, ATF2).

3. Key Contributions

• Discovery of LLPS in ATAD2: The study provides the first evidence that full-length ATAD2 undergoes liquid-liquid phase separation in both in vitro solutions and live cells.
• Identification of the Mediator: It establishes that the Bromodomain (BRD) is the primary driver of this phase separation, rather than the AAA+ ATPase domains.
• Mechanistic Link to Structure: The authors reveal a concentration-dependent conformational transition where ATAD2 BRD shifts from an α-helical structure to a β-sheet-dominant conformation during LLPS, a process regulated by disulfide bond formation.
• Functional Consequence: The study demonstrates that LLPS is not merely a structural phenomenon but a functional mechanism that enhances histone H4 acetylation (specifically H4K5ac) and drives chromatin remodeling.

4. Key Results

A. ATAD2 Undergoes LLPS Mediated by BRD

• Morphology: ATAD2 BRD and full-length ATAD2 form spherical, droplet-like assemblies in vitro and in HeLa cell nuclei.
• Fluidity: FRAP analysis confirmed rapid fluorescence recovery, proving these assemblies possess liquid-like internal fluidity.
• BRD Dependency:
  • Truncation mutants lacking the BRD (DeBRD) showed significantly reduced droplet formation.
  • Mutants lacking both the BRD and the linker (DeLinker-BRD) failed to form droplets entirely.
  • Treatment with the BRD inhibitor GSK8814 progressively abolished LLPS, confirming the BRD's critical role.

B. Conformational Transition and Redox Sensitivity

• Structural Shift: As protein concentration increases, ATAD2 BRD undergoes a transition from α-helical to β-sheet structures (confirmed by CD and ThT assays).
• Redox Regulation: This transition is sensitive to redox conditions. Inhibiting disulfide bond formation (via DTT) suppresses the structural shift and slows the decay of NMR signals, indicating that disulfide bond formation is required for the conformational change accompanying LLPS.

C. LLPS Enhances Histone Acetylation

• In Vitro Kinetics: Adding ATAD2 BRD to an EP300-mediated acetylation assay significantly increased CoA production (a proxy for acetylation) in a concentration-dependent manner.
• Causality: When ATAD2 BRD was photo-crosslinked to prevent phase separation, the enhancement of acetylation was lost, proving that LLPS is the direct driver of increased acetylation efficiency.
• Cellular Enrichment: Immunoblotting of isolated cellular droplets confirmed the enrichment of H4K5ac within ATAD2 condensates.

D. Downstream Biological Impact

• Gene Upregulation: Cells exhibiting ATAD2-mediated LLPS showed significantly higher levels of H4K5ac and upregulated transcription of C-MYC, CCND3, and ATF2.
• Cell Cycle: The upregulation of these genes facilitates the G1-to-S phase transition, accelerating cell cycle progression and chromatin remodeling.
• Feedback Loop: The study hypothesizes a negative feedback mechanism where the surge in acetylation upregulates ATF2 (a known inhibitor of acetyltransferases) to maintain homeostatic balance.

5. Significance

• Novel Mechanism of Regulation: This paper redefines ATAD2 not just as a static "reader" of histone marks, but as a dynamic protein that utilizes phase separation to concentrate itself and its enzymatic partners at specific genomic loci, thereby dramatically increasing the efficiency of chromatin remodeling.
• Structural Insight: It resolves the "elusive" nature of the full-length ATAD2 structure by proposing that its functional state involves a dynamic, β-sheet-rich condensate mediated by the BRD, regulated by disulfide bonds.
• Therapeutic Implications: Given ATAD2's role as an oncogene in breast, liver, gastric, and lung cancers, these findings suggest that inhibiting the phase separation capability of ATAD2 (e.g., via BRD inhibitors or targeting disulfide bond formation) could be a novel therapeutic strategy to disrupt the oncogenic chromatin remodeling and cell cycle progression driven by ATAD2.
• Paradigm Shift: It reinforces the emerging paradigm that biomolecular condensates are central to the regulation of epigenetic machinery and gene expression.